Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 66 Gross Margin % is 12.88% as of Mar. 2026, which is 24% above its 10-year median of 10.37. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Leoclan Co ranks worse than 56.41% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Leoclan Co's Gross Profit for the
six
months ended in Mar. 2026 was 円3,127 Mil. Leoclan Co's Revenue for the
six
months ended in Mar. 2026 was 円24,281 Mil. Therefore, Leoclan Co's Gross Margin % for the quarter that ended in Mar. 2026 was 12.88%.
The historical rank and industry rank for Leoclan Co's Gross Margin % or its related term are showing as below:
TSE:7681'
s Gross Margin % Range Over the Past 10 Years
Min: 9.27 Med: 10.37 Max: 13.22
Current: 12.82
During the past 9 years, the highestGross Margin % of Leoclan Co was 13.22%. The lowest was 9.27%. And the median was 10.37%.
TSE:7681's Gross Margin % is ranked worse than 56.41% of 117
companies
in the Medical Distribution industry
Industry Median: 14.91
vs TSE:7681: 12.82
Leoclan Co had a gross margin of 12.88% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Leoclan Co was 5.40% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Leoclan Co had a gross margin of 12.88% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Leoclan Co Gross Margin % Related Terms
Leoclan Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Leoclan Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7681 vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Leoclan Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Leoclan Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Leoclan Co (TSE:7681) has a Gross Margin % of 12.88% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Leoclan Co and its competitors. This is 24% above median its historical median of 10.37. Over the past decade, Leoclan Co's Gross Margin % has ranged from 9.27 to 13.22. According to the industry distribution chart, Leoclan Co ranks #66 out of 117 companies in the Medical Distribution industry, placing it in the top 56.4%.
Is Leoclan Co's Gross Margin % too high?
Leoclan Co's current Gross Margin % of 12.88% is 24% above median its 10-year median of 10.37. Over the past 10 years, this metric has ranged from a low of 9.27 to a high of 13.22. The Medical Distribution industry median Gross Margin % is 14.91. Leoclan Co's value of 12.88% is 13.6% below this industry median. Based on the distribution chart, Leoclan Co ranks #66 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #66 out of 117 companies for Gross Margin %. This places Leoclan Co in the lower half of its industry. The industry median Gross Margin % is 14.91. Leoclan Co's value of 12.88% is 13.6% below this benchmark. Historically, Leoclan Co's own Gross Margin % has ranged from 9.27 to 13.22 over the past decade. While the company's 10-year median is 10.37 vs. the industry median of 14.91, Leoclan Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.91, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leoclan Co's current Gross Margin % of 12.88% is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current Gross Margin % is 12.88%, which is 24% above median its own 10-year median of 10.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current Gross Margin % is 12.88%, which is 24% above median its 10-year median of 10.37 and 13.6% below the Medical Distribution industry median of 14.91. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current Gross Margin % is 12.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
Gross Margin %: 12.88% (24% above median its 10-year median of 10.37)
GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
Industry Position: 13.6% below the Medical Distribution median (#66 of 117)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
